Document Detail

5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.
MedLine Citation:
PMID:  21625315     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycles with only minor toxicity and are in continuous partial response, with stable peripheral blood counts, at 29 and 30 cycles from treatment start.
M Greco; M Criscuolo; L Fianchi; E Fabiani; L Pagano; Mt Voso
Related Documents :
11426625 - A case of meningeal myeloma presenting as obstructive hydrocephalus--a therapeutic chal...
6474295 - Neisseria flavescens septicaemia with meningitis. a case report.
10408825 - Slow-resolving pneumonia secondary to bronchiolitis obliterans organizing pneumonia.
8055685 - Listeria meningitis: a case study.
17545955 - A case of resolution of an acute psychotic episode after high fever.
8963735 - Canine multiple cartilaginous exostoses: unusual manifestations and a review of the lit...
Publication Detail:
Type:  Journal Article     Date:  2011-03-15
Journal Detail:
Title:  Mediterranean journal of hematology and infectious diseases     Volume:  3     ISSN:  2035-3006     ISO Abbreviation:  Mediterr J Hematol Infect Dis     Publication Date:  2011  
Date Detail:
Created Date:  2011-05-31     Completed Date:  2011-07-14     Revised Date:  2013-04-16    
Medline Journal Info:
Nlm Unique ID:  101530512     Medline TA:  Mediterr J Hematol Infect Dis     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  e2011011     Citation Subset:  -    
Istituto di Ematologia, Università Cattolica Sacro Cuore, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Severe acute hepatitis B treated with entecavir.
Next Document:  Zygomycosis in Immunocompromised non-Haematological Patients.